Navigation Links
HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials
Date:5/7/2009

onsored clinical trials networks in the global effort to evaluate and monitor HIV drug treatments."

Based on several published studies, current molecular or PCR based diagnostic tests vary in their ability to detect and reliably quantify variant strains of HIV-1 and have been found to under-quantify them. "The performance and precision of the Abbott RealTime HIV-1 assay for detecting variant subtypes allows physicians to confidently measure viral levels and provide optimal drug treatment," O'Kelly said.

The NIH-sponsored networks include the: AIDS Clinical Trials Group, International Maternal Pediatric Adolescent AIDS Clinical Trials Group, HIV Prevention Trials Network, HIV Vaccine Trials Network, and Microbicide Trials Network. The networks are an affiliated group of national and international medical research institutions and investigators that conduct clinical HIV/AIDS research to develop safe and effective drugs, prevention strategies and HIV vaccines.

About the Abbott RealTime HIV-1 Test

The Abbott RealTime HIV-1 assay is among the most sensitive viral load tests available today. The test has demonstrated the ability to detect diverse group M subtypes of HIV (including all known non-B subtypes) as well as group N and O isolates.

The Abbott RealTime HIV-1 test is intended for use in conjunction with clinical presentation and other laboratory markers as an indicator of disease prognosis and for use as an aid in assessing viral response to antiretroviral treatment as measured by changes in plasma HIV-1 RNA levels. The assay is not intended to be used as a donor-screening test for HIV-1 or as a diagnostic test to confirm the presence of HIV-1 infection.

About the Abbott m2000 Instrument System

The Abbott RealTime HIV-1 test runs on the Abbott m2000, an automated system that us
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
2. GeoVaxs Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
3. German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008
4. Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General
5. Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees
6. Successful Results for Mymetics Corporations Mucosal HIV/AIDS Vaccine Viral Challenge Significantly Exceeds Expectations
7. NCPS Outraged at HIV/AIDS Medi-Cal Cuts
8. Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City
9. Test for Life Campaign Screens Record Number of DC Residents for HIV/AIDS
10. U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences Claims
11. On World AIDS Day, CHF International Calls for Community Mobilization and Local Capacity Building to Fight HIV/AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Cardium Therapeutics (NYSE Amex: CXM ) announced ... (Ad5PDGF-B/Collagen) in the Treatment of Diabetic Ulcers," at ... Conference held December 10-13, 2009 in St. Thomas, ... by top industry leaders and renowned researchers in ... Barbara K. Sosnowski, Cardium,s Vice President of Biologics ...
(Date:12/14/2009)... in Finland have gained access to more advanced ... from Varian Medical Systems (NYSE: VAR ... the Nordic region. Clinicians at Docrates Clinic in ... of radiotherapy to treat patients with multiple brain ... ,, RapidArc, which enables clinicians to deliver a ...
(Date:12/14/2009)... WALTHAM, Mass., Dec. 14 According ... authority on medical technology market intelligence, Japan,s ... process has created a significant lag in ... country compared to other developed nations. ... Vascular Devices 2010 report finds, however, ...
Breaking Medicine Technology:Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 2Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 3Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 4Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 3Japanese Peripheral Vascular Stent Procedures to Experience 11% Growth Through 2014 2Japanese Peripheral Vascular Stent Procedures to Experience 11% Growth Through 2014 3Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 1Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 2Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 3Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 4Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 5Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 6Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 7ACTEMRA 28R 29 28tocilizumab 29 Studies to be Featured at the European League Against Rheumatism 28EULAR 29 Congress 47894 1ACTEMRA 28R 29 28tocilizumab 29 Studies to be Featured at the European League Against Rheumatism 28EULAR 29 Congress 47894 2ACTEMRA 28R 29 28tocilizumab 29 Studies to be Featured at the European League Against Rheumatism 28EULAR 29 Congress 47894 3ACTEMRA 28R 29 28tocilizumab 29 Studies to be Featured at the European League Against Rheumatism 28EULAR 29 Congress 47894 4SignatureForum Reveals Top Rated Aesthetic Medical Practices in U S 47889 1SignatureForum Reveals Top Rated Aesthetic Medical Practices in U S 47889 2SignatureForum Reveals Top Rated Aesthetic Medical Practices in U S 47889 3
... Pharmacy, one,of the largest privately owned national specialty ... agreement with Genzyme Corporation to,administer their 2008 Renagel ... world,s largest biotechnology companies dedicated to products,and services ... and oncology., Diplomat will be the 2008 ...
... Inc. (OTC,Bulletin Board: GOVX), an Atlanta-based biotechnology company ... "2008 Deal of the Year",award winner by Georgia ... million IPCAVD (Integrated Preclinical/Clinical AIDS VACCINE,Development grant) from ... The award will be presented at Georgia Bio,s ...
Other Medicine Technology:Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program 2GeoVax Labs, Inc. Selected by Georgia Bio as '2008 Deal of the Year' Award Winner in Life Sciences Industry 2GeoVax Labs, Inc. Selected by Georgia Bio as '2008 Deal of the Year' Award Winner in Life Sciences Industry 3GeoVax Labs, Inc. Selected by Georgia Bio as '2008 Deal of the Year' Award Winner in Life Sciences Industry 4
(Date:12/14/2009)... procedures vary widely and are higher than generally thought, raising concerns ... by University of California, San Francisco (UCSF) imaging specialists. ... ... -- Radiation doses from common CT procedures vary widely and are ... according to a new study led by University of California, ...
(Date:12/14/2009)... -- Grubb & Ellis Healthcare REIT II, Inc. announced today ... to stockholders of record as of the close of business ... 2010 and ending on Feb. 28, 2010. The distributions ... year and will be equal to an annualized distribution rate ... share. These distributions will be aggregated and paid in ...
(Date:12/14/2009)... whose disease had been treated, hadn,t spread, study finds ... to reduce the risk of death in male colon ... in January 1986, included 668 men who,d been treated ... cancer that had not spread (nonmetastatic cancer). Every two ... about any new cancer and disease diagnoses, as well ...
(Date:12/14/2009)... the UC San Diego School of Medicine and Osaka ... helps prevent liver damage, including inflammation, fibrosis and cancer. ... the protein, TAK1, works could lead to new insights ... , "TAK1 appears to be a master regulator of ... medicine and Dean of the UC San Diego School ...
(Date:12/14/2009)... age to physical, mental functioning , , , MONDAY, Dec. ... their age tend to live longer than those who ... , The finding came from research that involved 1,826 ... physical and cognitive tests and then had their faces ... and indicated the age they perceived the participants to ...
Breaking Medicine News(10 mins):Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 2Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 3Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 4Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 5Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 2Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 3Health News:Physical Activity May Prolong Survival After Colon Cancer 2Health News:Scientists uncover protective mechanism against liver cancer 2Health News:Looking Younger Than Your Age May Mean Longer Life 2
... Health Association (APHA) today released its annual congressional voting record, which ... to public health. , , APHA,s report ... public health votes during the second session of the 110th Congress ... of 100 senators voted in support of APHA,s position on all ...
... WASHINGTON, Feb. 2 Risky Business: Managing ... in its Second Edition by FDAnews. Authored by ... at Becker & Associates Consulting (Washington, DC), the book ... industry. The update for the Second Edition is ...
... benefit more from non-invasive treatmentsROSEMONT, Ill., Feb. 2 ... actually be the best method. A literature study published ... of the American Academy of Orthopaedic Surgeons ( ... lumbar degenerative disk disease, a common cause of low ...
... Feb. 2 Pet advocates are encouraging,pet owners to ... National Pet,Dental Health Month this February. And it ... provider PetFirst Healthcare saw claims,for illnesses related to oral-health ... "Many pet owners don,t place as much ...
... Inc. Experiences Increase in Sales at Pharmacy Retail Level, ... Fla., Feb. 2 American Scientific Resources (Pink Sheets: ... by 38% in the 4th quarter of 2008 compared ... safety products company reports that despite the economic recession, ...
... Calling all high school seniors --,there are only a ... Athlete Milk,Mustache of the Year (SAMMY) Awards and potentially ... This unique award, sponsored by the National ... educates teens on the importance of,making smart choices -- ...
Other Medicine News:Health News:APHA Voting Record Tracks How Members of Congress Voted on Public Health Legislation 2Health News:New Book Prescribes Quality Guidance for Pharma Industry as Criticism of FDA and Consumer Safety Concerns Surge 2Health News:Avoiding Surgery for Low Back Pain 2Health News:Avoiding Surgery for Low Back Pain 3Health News:Pet Dental Claims Skyrocket 2Health News:Q4 2008 Sales Increase for Health and Safety Products Company 2Health News:Q4 2008 Sales Increase for Health and Safety Products Company 3
... you've come to demand in BD K-3000 ... K-4000 microkeratome is built upon. , ,The ... The front panel on the new console ... bright visual feedback., ,The BD K-4000 Microkeratome ...
... third-generation allergy test , 3gAllergy is a ... provides quantitative determination of allergen-specific IgE at ... and lot-to-lot reproducibility. The assay delivers reliable ... you identify, monitor and manage patients with ...
The properties of titanium alloy have been combined with a uniquely designed reverse radial tapping flute to produce a state-of-the-art fracture fixation system....
Biomet® Arthrodesis Nail indications include: , Failed external fixation , Aseptic failed total knee arthroplasty , Periarticular fractures where repair is not possible , Limb salvage in tumor...
Medicine Products: